Treatment of resistant pain in hypertrophic pulmonary arthropathy with ketorolac.

Pain associated with hypertrophic pulmonary osteoarthropathy (HPOA) may be extremely disabling and resistant to treatment. The successful use of ketorolac, a new non-steroidal anti-inflammatory drug, given by subcutaneous infusion is reported in two patients with uncontrolled pain caused by HPOA.

Detalhes bibliográficos

Publicado no:	Thorax
Principais autores:	Blackwell, N, Bangham, L, Hughes, M, Melzack, D, Trotman, I
Formato:	Artigo
Idioma:	Inglês
Publicado em:	BMJ Publishing Group 1993
Assuntos:	Research Article
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC464442/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8511741/ https://ncbi.nlm.nih.govhttps://doi.org/10.1136/thx.48.4.401
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!